Canonical: https://ownershiptrace.com/13f/companies/4364

# Who owns Artiva Biotherapeutics, Inc. (ARTV)? Elite investor 13F holders

3 tracked elite investors reported holding Artiva Biotherapeutics, Inc as of 2026-06-30, including Viking Global Investors, Caligan Partners, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis,…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Viking Global Investors](https://ownershiptrace.com/13f/investors/81) | ARTIVA BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 25260410.00 USD | 2604166.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1103804/0001103804-26-000006-index.html) |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | ARTIVA BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16840277.00 USD | 1736111.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ARTIVA BIOTHERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1464700.00 USD | 151000.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)